Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.

Results: 1624 (Showing 1 to 20)
Name Principal Investigator Institution Study Date Approved Project ID
Covariate data for new set of controls for GWAS studies Rachael Stolzenberg-Solomon DCEG, NCI PLCO Mar 27, 2024 PLCO-1515
Enhancing Lung Cancer Treatment Decisions through AI-driven Analysis of PLCO Patient Data Ricardo Gonzales Vera University of Oxford PLCO Mar 27, 2024 PLCO-1514
Adherence to the EAT-Lancet dietary pattern reduces the risk of renal cancer in the PLCO Cancer Screening Trial Linglong Peng The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. PLCO Mar 27, 2024 PLCO-1513
Identifying novel genetic factors predisposing to inherited cardiac disorders Connie Bezzina Amsterdam Universitair Medisch Centrum PLCO Mar 25, 2024 PLCO-1507
Anthocyanin and ovarian cancer risk: a prospective study in the Prostate, Lung, Colorectal and Ovarian (PLCO) cohort Huijun Huang Wenzhou medical university PLCO Mar 25, 2024 PLCO-1506
Lung and Cardiovascular Disease Detection with Large Scale, Disease Screening Chest X-rays Pingkun Yan Rensselaer Polytechnic Institute PLCO Mar 25, 2024 PLCOI-1505
Check if CXR can be implemented as a biomarker for aging. changduk Seo Kyungpook National University PLCO Mar 15, 2024 PLCOI-1497
Early Detection of Breast Cancer with AI enhanced workflows Dr. Tariq Mahmood Institute of Business Administration PLCO Mar 13, 2024 PLCO-1496
Association between adherence to Eat-Lancet diet and incidence and mortality of liver cancer: A prospective cohort study Lifu Lei The Second Affiliated Hospital of Chongqing Medical University PLCO Mar 11, 2024 PLCO-1491
Computational Feature Profiling and Modeling for Prostate Cancer Detection and Risk Stratification Corey Arnold University of California, Los Angeles PLCO Mar 11, 2024 PLCOI-1492
Assess positive-sum fairness of CXR classifiers leveraging demographic attributes Samia Belhadj Lunit Inc. PLCO Feb 27, 2024 PLCO-1490
Alcohol intake and the risk of colorectal adenomas and colorectal cancer in the PLCO (NCI Version) Erikka Loftfield (240)762-3319 PLCO Feb 27, 2024 PLCO-1489
Artificial Intelligence-Based Pathological Model for Predicting Biochemical Recurrence in Prostate Cancer: a Multicenter Study Rui Chen Shanghai Jiao Tong University School of Medicine PLCO Feb 26, 2024 PLCOI-1486
Ethnic and molecular diversity in prostate cancer Lisa Smith University of Nebraska at Omaha PLCO Feb 26, 2024 PLCO-1488
Characterizing polyp progression and its relationship to colorectal cancer in a longitudinal study Scott Lipnick Flagship Labs LLC PLCO Feb 26, 2024 PLCO-1485
Development of Medical AI for Cancer Diagnosis and Area Detection hyunwoo kim VUNO PLCO Feb 26, 2024 PLCOI-1484
Development of non-invasive biomarkers to assess disease progression using patients diagnostic imaging and clinical data Yoganand Balagurunathan H Lee Moffitt Cancer Center and Research Institute PLCO Feb 26, 2024 PLCOI-1469
Is there a correlation between the age of the diagnosed prostate cancer patient and initial PSA result and final staging Alistair Wright Open University PLCO Feb 26, 2024 PLCO-1482
Examining the performance of weighting methods under different populations Lei Song George Washington University PLCO Feb 15, 2024 PLCO-1480
The Impact of Location of Colon Polyps at Colonoscopy on Risk of Colorectal Cancer Incidence and Mortality: Secondary Analyses of the PLCO Trial Paolo Goffredo University of Minnesota PLCO Feb 14, 2024 PLCO-1465